Bascom Palmer Eye Institute

Running trials

• Not yet recruiting

  VGFTe-(HD)-OD-2566: Adjunctive Aflibercept Ahmed Glaucoma Valve (AAA) Study

  NCT07891182· Phase 2· Source

• Recruiting

  Biomarkers of Ocular Surface Damage in the Setting of Topical Ocular Hypotensive Medication Use

  NCT07217678· Phase 4· Source

• Active, not recruiting

  A Phase 2 Open-label Study to Evaluate the Safety of Laruparetigene Zovaparvovec Administered Bilaterally in Male Participants With X-Linked Retinitis Pigmentosa

  NCT07174726· Phase 2· Source

• Recruiting

  A Phase 1/2, First-in-Human Dose Escalation/Expansion Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of a Subretinal Injection of SB-007 in Subjects With Stargardt Disease (STGD1)

  NCT06942572· Phase 1/2· Source

• Active, not recruiting

  Study to Evaluate ACDN-01 in ABCA4-related Stargardt Retinopathy (STELLAR)

  NCT06467344· Phase 1/2· Source

• Recruiting

  An Observational Study in Subjects to Follow the Progression of Stargardt Disease Type 1 (STGD1) Caused by Bi-Allelic Autosomal Recessive Mutations in the ABCA4 Gene

  NCT06435000· Source

• Enrolling by invitation

  A Study Comparing Two Doses of AGTC-501 in Male Participants With X-linked Retinitis Pigmentosa Caused by RPGR Mutations (DAWN)

  NCT06275620· Phase 2· Source

• Active, not recruiting

  A Phase 2/3 Trial to Assess the Efficacy and Safety of OCU410ST for Stargardt Disease

  NCT05956626· Phase 2/3· Source

• Recruiting

  Glaucoma Drainage Device and Endothelial Cell Loss Compare Trial

  NCT05924477· Source

• Recruiting

  Pancreatic Islet Transplantation Into the Anterior Chamber of the Eye

  NCT02846571· Phase 1/2· Source

• Recruiting

  Clinical Applications of Advanced Ophthalmic Imaging

  NCT03135327· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Glaucoma3 recruiting
• Diabetic eye disease1 recruiting
• High blood pressure1 recruiting
• Macular degeneration1 recruiting
• Multiple sclerosis1 recruiting
• Retinitis pigmentosa1 recruiting
• Type 1 diabetes1 recruiting
• Type 2 diabetes1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  Patient Performance on Virtual Reality Visual Field Devices as Compared to Standard of Care

  NCT04994457· Source

• Completed

  An Extension Study to Evaluate the Long-term Safety and Efficacy of Pegcetacoplan (APL-2) in Subjects With Geographic Atrophy Secondary to AMD

  NCT04770545· Phase 3· Source

• Terminated

  HORIZON: A Phase II Study to Evaluate the Safety and Efficacy of Two Doses of GT005

  NCT04566445· Phase 2· Source

• Terminated

  EXPLORE: A Phase II Study to Evaluate the Safety and Efficacy of Two Doses of GT005

  NCT04437368· Phase 2· Source

• Completed

  A Patient Registry Study for Patients Treated With Voretigene Neparvovec in US

  NCT03597399· Source

• Completed

  PRIMA US-Feasibility Study in Atrophic Dry AMD

  NCT03392324· Source